Mediation of circadian rhythms

Simple item page
dc.contributor.assigneeLuminis Pty Limited
dc.contributor.authorKennaway, D.
dc.date.issued2002
dc.descriptionUnited States Patent 6403651
dc.description.abstractMethod for mediating the effects of light on melatonin rhythmicity in mammals and a method of mediating circadian rhythms, effected by the administration of a compound or compounds effective at a 5-HT2c serotonin receptor site. By administration of selected doses of the 5-HT2c receptor active compound it is possible to advance or delay circadian rhythms as measured by the rate of melatonin production or moderation of core body temperature rhythms.
dc.description.statementofresponsibilityDavid Kennaway
dc.description.urihttp://www.patentstorm.us/patents/6403651.html
dc.identifier.orcidKennaway, D. [0000-0002-5864-3514]
dc.identifier.patent6403651
dc.identifier.urihttp://hdl.handle.net/2440/39060
dc.language.isoen
dc.titleMediation of circadian rhythms
dc.typePatent
pubs.publication-statusPublished

Files

Collections

Medical Sciences publications